Outlook Therapeutics CEO Lawrence Kenyon's 2020 pay falls 36% to $1.2M

Outlook Therapeutics reports 2020 executive compensation

By ExecPay News

Published: February 22, 2021

Outlook Therapeutics reported fiscal year 2020 executive compensation information on February 22, 2021.
In 2020, three executives at Outlook Therapeutics received on average a compensation package of $501K, a 73% decrease compared to previous year.
Average pay of disclosed executives at Outlook Therapeutics
Lawrence A. Kenyon, Chief Executive Officer, received $1.2M in total, which decreased by 36% compared to 2019. 52% of Kenyon's compensation, or $621K, was in option awards. Kenyon also received $117K in bonus, $425K in salary, as well as $21K in other compensation.
Terry Dagnon, Chief Operating Officer, received a compensation package of $160K. 100% of the compensation package, or $160K, was in other compensation.
Jeff Evanson, Chief Commercial Officer, earned $160K in 2020.
Outlook Therapeutics' fiscal year ends on September 30.

Related executives

Lawrence Kenyon

Outlook Therapeutics

Chief Executive Officer

Terry Dagnon

Outlook Therapeutics

Chief Operating Officer

Jeff Evanson

Outlook Therapeutics

Chief Commercial Officer

You may also like

Source: SEC filing on February 22, 2021.